Canton Biotechnologies Overview

  • Founded
  • 2004
Founded
  • Status
  • Private
  • Employees
  • 2
Employees
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $512K
Latest Deal Amount
  • Investors
  • 5

Canton Biotechnologies General Information

Description

Developer of innovative wound healing technology intended to provide high-value therapeutics. The company's technology uses CA5 HIF plasmid transfection with electroporation, enabling patients and health institutions to avail fast and effective cure to accelerate wound healing in acute and chronic wounds.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Outcome Management (Healthcare)
Primary Office
  • 2901 Boston Street
  • Suite 606
  • Baltimore, MD 21224
  • United States
+1 (410) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Canton Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jan-2015 $512K 0000 Completed Generating Revenue
2. Early Stage VC 17-Aug-2006 0000 0000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Canton Biotechnologies’s complete valuation and funding history, request access »

Canton Biotechnologies Executive Team (2)

Name Title Board Seat Contact Info
John Harmon MD President
To view Canton Biotechnologies’s complete executive team members history, request access »

Canton Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Canton Biotechnologies Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
To view Canton Biotechnologies’s complete investors history, request access »